Shares of several communications and media companies are trading higher as equities gain amid a report suggesting Gilead Sciences' Remdesivir drug showed some effectiveness in treating the coronavirus. This has raised hopes of a sooner return to spending, economic activity, and investment.
Benzinga Newsdesk